Both in Biotechnology
VivoSim Labs vs Liminatus Pharma
Over the past year VIVS returned −93.6% and LIMN returned −95.9%; their daily moves had a correlation of 0.01.
VIVS −93.6% LIMN −95.9%Growth of $1, one year, split-adjusted
| Metric | VIVS | LIMN |
|---|---|---|
| Price | $0.1457 | $2.92 |
| Market cap | $2.0M | $3.9M |
| Today | −3.06% | +1.04% |
| 1 month | −28.0% | −25.3% |
| 6 months | −89.9% | −71.4% |
| Year to date | −92.0% | −90.4% |
| 1 year | −93.6% | −95.4% |
| Revenue growth (YoY) | −51.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −7433.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 17.4× | — |
| Net cash | $1.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 116.0% | 1,152.8% |
| Short % of float | 4.0% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).